[CLDX] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
26-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -15.19%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 6,883 2,357 4,651 7,418 3,573 9,538 12,743 -9.75%
PBT -141,429 -112,325 -70,738 -60,947 -50,878 -151,949 -117,313 3.16%
Tax 0 10,458 -227 -1,167 -506 -765 -24,282 -
NP -141,429 -122,783 -70,511 -59,780 -50,372 -151,184 -93,031 7.22%
Tax Rate - - - - - - - -
Total Cost 148,312 125,140 75,162 67,198 53,945 160,722 105,774 5.79%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -2,054.76 -5,209.29 -1,516.04 -805.88 -1,409.80 -1,585.07 -730.06 18.81%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -2.92 -2.62 -1.64 -2.02 -3.47 -14.48 -10.86 -19.65%
EPS Diluted -2.92 -2.62 -1.64 -2.02 -3.47 -14.48 -10.86 -19.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.